Said Rahim

424 total citations
11 papers, 314 citations indexed

About

Said Rahim is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Said Rahim has authored 11 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Neurology. Recurrent topics in Said Rahim's work include Prostate Cancer Treatment and Research (4 papers), Neurofibromatosis and Schwannoma Cases (3 papers) and Signaling Pathways in Disease (2 papers). Said Rahim is often cited by papers focused on Prostate Cancer Treatment and Research (4 papers), Neurofibromatosis and Schwannoma Cases (3 papers) and Signaling Pathways in Disease (2 papers). Said Rahim collaborates with scholars based in United States, Türkiye and Poland. Said Rahim's co-authors include Aykut Üren, Jeffrey A. Toretsky, Milton L. Brown, Yali Kong, Elspeth M. Beauchamp, Jenny Han, Yasemin Saygıdeğer, Tsion Z. Minas, Haydar Çelik and Kamal P. Sajwan and has published in prestigious journals such as PLoS ONE, Molecular and Cellular Biology and Cancer Research.

In The Last Decade

Said Rahim

11 papers receiving 312 citations

Peers

Said Rahim
Stephen Schmidt United States
Emily Eugster United States
Anne Tann United States
Amy Haseley Thorne United States
Ladan Zolfaghari United States
Ethan J. Brock United States
Stephen Schmidt United States
Said Rahim
Citations per year, relative to Said Rahim Said Rahim (= 1×) peers Stephen Schmidt

Countries citing papers authored by Said Rahim

Since Specialization
Citations

This map shows the geographic impact of Said Rahim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Said Rahim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Said Rahim more than expected).

Fields of papers citing papers by Said Rahim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Said Rahim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Said Rahim. The network helps show where Said Rahim may publish in the future.

Co-authorship network of co-authors of Said Rahim

This figure shows the co-authorship network connecting the top 25 collaborators of Said Rahim. A scholar is included among the top collaborators of Said Rahim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Said Rahim. Said Rahim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Czarnik, Tomasz, et al.. (2017). Vitamin D kinetics in the acute phase of critical illness: A prospective observational study. Journal of Critical Care. 43. 294–299. 19 indexed citations
2.
Çelik, Haydar, Kamal P. Sajwan, Saravana P. Selvanathan, et al.. (2015). Ezrin Binds to DEAD-Box RNA Helicase DDX3 and Regulates Its Function and Protein Level. Molecular and Cellular Biology. 35(18). 3145–3162. 30 indexed citations
3.
Rahim, Said, Tsion Z. Minas, Haydar Çelik, et al.. (2014). A Small Molecule Inhibitor of ETV1, YK-4-279, Prevents Prostate Cancer Growth and Metastasis in a Mouse Xenograft Model. PLoS ONE. 9(12). e114260–e114260. 43 indexed citations
4.
Kong, Yali, Lauren Scher, Jeffrey A. Schneider, et al.. (2014). Synthesis and Structure–Activity Relationship Studies of Small Molecule Disruptors of EWS-FLI1 Interactions in Ewing’s Sarcoma. Journal of Medicinal Chemistry. 57(24). 10290–10303. 12 indexed citations
5.
Paige, Mikell, Matthew Miessau, Said Rahim, et al.. (2013). Design, synthesis and biological evaluation of ezrin inhibitors targeting metastatic osteosarcoma. Bioorganic & Medicinal Chemistry. 22(1). 478–487. 21 indexed citations
6.
Rahim, Said, Yali Kong, Milton L. Brown, et al.. (2013). Abstract 5453: YK-4-279 inhibits ETS-positive prostate cancer cell metastasis in a mouse xenograft model.. Cancer Research. 73(8_Supplement). 5453–5453. 1 indexed citations
7.
Rahim, Said & Aykut Üren. (2013). Emergence of ETS transcription factors as diagnostic tools and therapeutic targets in prostate cancer.. PubMed. 5(3). 254–68. 20 indexed citations
8.
Briggs, Joseph, Ling Ren, Rachel Nguyen, et al.. (2012). The Ezrin Metastatic Phenotype Is Associated with the Initiation of Protein Translation. Neoplasia. 14(4). 297–IN5. 25 indexed citations
9.
Rahim, Said & Aykut Üren. (2011). A Real-time Electrical Impedance Based Technique to Measure Invasion of Endothelial Cell Monolayer by Cancer Cells. Journal of Visualized Experiments. 55 indexed citations
10.
Rahim, Said & Aykut Üren. (2011). A Real-time Electrical Impedance Based Technique to Measure Invasion of Endothelial Cell Monolayer by Cancer Cells. Journal of Visualized Experiments. 10 indexed citations
11.
Rahim, Said, Elspeth M. Beauchamp, Yali Kong, et al.. (2011). YK-4-279 Inhibits ERG and ETV1 Mediated Prostate Cancer Cell Invasion. PLoS ONE. 6(4). e19343–e19343. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026